We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OOMA:NYSEOoma, Inc. Analysis

Data as of 2026-08-25 - not real-time

$20.86

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Ooma, Inc. is bullish at $20.86, with short-term averages leading the long-term ones. Over a rolling month the price has gained 1.5%. RSI sits at 50.7, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $19.72 and resistance at $22.72.
Valuation screens as overvalued: a P/E of 63.2 sits above the sector average of 34.9. The average analyst target implies 10.3% above today's level. Revenue is growing at 24.8% on a 3.2% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 47.8%, a beta of 0.62 and a maximum drawdown of 20.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

SUNNYVALE, Calif., August 05, 2026--Ooma, Inc. NYSE: OOMA , a leading provider of communications solutions for...DALLAS,, August 04, 2026--Thryv and Ooma enter a co-marketing agreement, creating new opportunities to introduce their...2dTune Into Ooma For A Potential Earnings BreakoutOoma could break out before Aug 26 Q2 earnings as growth drivers and...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 15.36
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 63.2 versus sector average of 34.9
  • Trading above the 200-day average of 15.36

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 63.2 versus sector average of 34.9
  • Analyst targets imply +10.3% versus the current price
  • Revenue growth of +24.8%

Key Metrics & Analysis

Financial Health

Revenue Growth24.80%
Profit Margin3.17%
P/E Ratio63.2
ROE10.00%
ROA3.04%
Debt/Equity70.82
P/B Ratio6.0
Op. Cash Flow$30.4M
Free Cash Flow$35.6M
Industry P/E34.9

Technical Analysis

TrendBullish
RSI50.7
Support$19.72
Resistance$22.72
MA 20$21.15
MA 50$20.13
MA 200$15.36
MACDBearish
VolumeStable
Fear & Greed Index93.27

Valuation

Fair Value$42.71
Target Price$23.00
Upside/Downside10.29%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.62
Volatility47.82%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.